News Daily News Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months Michael O'Riordan December 01, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
News Daily News Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI Yael L. Maxwell December 22, 2015
News Daily News Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene L.A. McKeown July 13, 2015
News Daily News After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist L.A. McKeown July 13, 2015
News Daily News ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy April 29, 2015
News Daily News Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years Caitlin E. Cox July 12, 2012